Results 31 to 40 of about 1,518,600 (268)
trans-Dichloridotetrakis(pyridine-κN)rhodium(III) chloride methanol tetrasolvate
IUCrData, 2018 In the solvated title salt, [RhCl2(C5H5N)4]Cl·4CH3OH, the RhIII atom lies on a special position of 2.22 site symmetry. Consequently, the cationic complex has molecular D2 symmetry with a trans disposition for two equivalent Cl− and four equivalent ...
Takayoshi Suzuki +2 more
doaj +1 more source
A bright tetranuclear iridium(iii) complex
Chemical Communications, 2011 A cyclic tetranuclear cyclometallated iridium(III) complex using cyanide anions as bridging ligands and displaying a tetrahedrally distorted square geometry has been obtained with high yield; photo- and electrochemical characterizations show that most interesting properties of mononuclear cyclometallated iridium complexes are retained in the ...
Baranoff, Etienne +6 more
openaire +3 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier +10 more
wiley +1 more source
Acta Chimica Slovenica, 2017 Novel tetrachloridoruthenium(III) complex Na[trans-RuCl4(DMSO)(PyrDiaz)] (3) with pyridine-tethered diazenedicarboxamide PyrDiaz ligand (PyrDiaz = N1-(4-isopropylphenyl)-N2-(pyridin-2-ylmethyl)diazene-1,2-dicarboxamide) was synthesized by direct coupling
Jure Vajs +6 more
doaj +1 more source
Magnetochemistry, 2021 Two carboxylate-bridged one-dimensional chain complexes, {[MnII(MeOH)2][FeIII(L)2]2}n (1) and {[MnII(DMF)2][MnIII(L)2]2·DMF}n (2) [H2L = ((2-carboxyphenyl)azo)-benzaldoxime], containing a low-spin [FeIII(L)2]− or [MnIII(L)2]− unit were synthesized ...
Min Zeng, Xi Chen, Hui-Zhong Kou
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar +7 more
wiley +1 more source
Frontiers in ImmunologyIntroductionMultiple sclerosis (MS) is a neuroinflammatory complex disease of the central nervous system (CNS). Diagnosing MS remains challenging due to its nonspecific signs, highlighting the need for reliable biomarkers.
Adela González-Jiménez +5 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT In 2018, the Texas Children's Cancer and Hematology Center Leukemia Program implemented a practice standard to support the transition from treatment to survivorship that includes shared, alternating care between leukemia and survivorship clinicians and a reminder to refer survivors to the long‐term survivor clinic (LTSC) 2 years after ...
Ji Yun Tark +9 more
wiley +1 more source
Biologically‐Active Gold(III) Complexes [PDF]
Metal-Based Drugs, 1998 A review is given of the background to and results of the succesful pharmacological testing of [AuX2(damp)] (X = Cl, OAc; damp = 2 − Me2NCH2C6H4) against a range of microbes, fungi and tumouts, culminating in in vivo xenografts of ZR‐1‐75. These are the first fully evaluated gold(III) complexes.
openaire +2 more sources
The Role of “Adult‐Onset” Cancer Predisposition Genes in Pediatric Cancer: A Comprehensive Review
Pediatric Blood &Cancer, EarlyView.ABSTRACT Current literature estimates that 10% of pediatric cancers are caused by pathogenic or likely pathogenic (P/LP) germline variants in cancer predisposition genes (CPGs). Variants in CPGs thought to increase cancer risk exclusively during adulthood are referred to as “adult‐onset” CPGs (aoCPGs).
Maria Rozo +5 more
wiley +1 more source